Pfizer on Wednesday asked the US to authorize extra-low doses of its Covid-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. In an extraordinary move, the Food and Drug Administration had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned.
Pfizer on Wednesday asked the US to authorize extra-low doses of its Covid-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. In an extraordinary move, the Food and Drug Administration had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned. from Times of India https://ift.tt/mtLRZdnPD
Pfizer on Wednesday asked the US to authorize extra-low doses of its Covid-19 vaccine for children under 5, potentially opening the way for the very youngest Americans to start receiving shots as early as March. In an extraordinary move, the Food and Drug Administration had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned. from Times of India https://ift.tt/mtLRZdnPD
Comments
Post a Comment